Please provide your email address to receive an email when new articles are posted on . Facial identity discrimination accuracy decreased by 20.4% under low luminance for those with central vision ...

Please provide your email address to receive an email when new articles are posted on . Laru-zova demonstrated a positive safety profile and early efficacy in improving low luminance visual acuity in ...

Data presented at ARVO 2026 show that high-dose gene therapy boosts central retinal sensitivity in X-linked retinitis ...

A review found that global retinal sensitivity changes in mesopic and scotopic lighting were significant in age-related macular degeneration (AMD). Age-related macular degeneration (AMD) had a ...

A gene therapy that targets a form of retinitis pigmentosa showed a signal to improve retinal function for up to 3 years after treatment, according to a small clinical trial. The phase 2 SKYLINE trial ...

The biotechnology company disclosed interim human trial data for its RV-001 optogenetic treatment aiming to restore sight in ...